Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-05-29
1999-05-04
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530385, A01N 3718, A61K 3816, C07K 1400, C07K 1600
Patent
active
059004029
ABSTRACT:
A method of reducing side-effects associated with administering oxygen-carrying proteins to mammals is disclosed. The method includes:
REFERENCES:
patent: 5028588 (1991-07-01), Hoffman et al.
patent: 5079337 (1992-01-01), Leonard et al.
patent: 5234903 (1993-08-01), Nho et al.
patent: 5312808 (1994-05-01), Shorr et al.
patent: 5321095 (1994-06-01), Greenwald
patent: 5324844 (1994-06-01), Zalipsky
patent: 5349001 (1994-09-01), Greenwald et al.
patent: 5386014 (1995-01-01), Nho et al.
patent: 5478805 (1995-12-01), Shorr et al.
patent: 5599907 (1997-02-01), Anderson et al.
patent: 5605976 (1997-02-01), Martinez et al.
patent: 5658879 (1997-08-01), Nho
Looker, D. et al., "A Human Recombinant Haemoglobin Designed For Use as a Blood Substitute", Mar. 19, 1992; vol. 356, pp. 258-260.
Winslow, R. M., et al. Physiologic Effects of Hemoglobin-based Oxygen Carriers compared to Red Blood Cells in Acute Hemorrhage; Abstract #2494, p. 626a, Blood vol. 88, No. 10. Supp. 1; Nov. 15, 1996.
Conover, C.D., et al. The Effects of Hemodilution with Polyethylene Glycol Bovine Hemoglobin (PEG-Hb) in a Conscious Porcine Model; J. Investig. Med. 44:238-246; 1996.
Conover, C. D., et al. Physiological Effect of Polyethylene Glycol Conjugation on Stroma-Free Bovine Hemoglobin in the Conscious Dog After Partial Exchange Transfusion; Artificial Organs 21(5):369-378; 1997.
Conover, C.D., et al. Effect of Polyethylene Glycol Conjugated Bovine Hemoglobin in Both Top-Load and Exchange Transfusion Rat Models; Artificial Organs 21(10):1066-1075; 1997.
Conover, C.D., et al. The Influence of Polyethylene Glycol Conjugation on Bovine Hemoglobin's Intrinsic Effect on the Gastrointestinal System of the Rat; Life Sciences, vol. 59, No. 22;pp. 1861-1869; 1996.
Shum, K. L., et al. The Physiological & Histopathological Response of Dogs to Exchange Transfusion w/Polyethylene Glycol-Modified Bovine Hemoglobin; Art Cells Blood Subs and Immob Biotech; 24(6) pp. 655-683; 1996.
Song D., et al. Comparison of the Efficacy of Blood and Polyetylene Glycol-Hemoglobin in Recovery of Newborn Piglets from Hemorrhagic Hypotension: Effect on Blood Pressure . . . ; Transfusion vol. 35, No. 7, 552-558; 1995.
Shorr, R. G. L., et al. Polythylene Glycol Modified Hemoglobin: Effects on Blood Pressure and Heart Rate in the Canine; Abstract from Presentation at Experimental Biology 94 Convention; 1994.
Enzon Inc.
Marshall S. G.
Tsang Cecilia J.
LandOfFree
Method of reducing side effects associated with administration o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of reducing side effects associated with administration o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing side effects associated with administration o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1869586